Sangel Capital is one of the earliest professional biomedical venture capital institutions in China, focusing on the field of life science. We have a leading professional advantage and abundant project resources in the domestic biomedical investment area. Based on the most promising industry, Sangel Capital taps innovative growth enterprises with great capital value and commercial potential, and trains a number of industry benchmarks.
Company Details
- Founded
- -
- Address
- Room 2401/2402, No. 1001 Keyuan Road, Shenzhen,nanshan 518000,china
- li****@****lvc.com
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- sangelvc.com
- HQ
- Shenzhen, Nanshan
Sangel Capital Questions
Sangel Capital's website is sangelvc.com
Sangel Capital's LinkedIn profile is https://cn.linkedin.com/company/sangel-capital
Sangel Capital's industry is
Venture Capital and Private Equity Principals
Sangel Capital's top competitors are
Pivotal Bioventure China,
Liquidity Capital 流动资本,
Sangel,
Sherpa Healthcare Partners (夏尔巴投资),
Spade Capital（黑桃资本）,
Pivotal Bioventure Partners,
Cd Capital,
Tao Capital,
五岳资本n5capital,
Fermi Ventures.
Sangel Capital's support email address is liuyanzhan@sangelvc.com
Sangel Capital's categories are Venture Capital and Private Equity Principals
Sangel Capital's founding year is 2009
